Immunoblotting results presented in Fig. 5G indicated that the KDM6 inhibitor GSK-J4 suppressed the expression of IGF1 and ELN in AOM/DSS-induced colon cancer but had minimal effect on KDM6A protein levels. The gene discussed is KDM6A; the disease is malignant colon neoplasm.